{"public_id":"cl_015dc08829e7012ef0df91b1abbe9f9b","status":"active","superseded_by_public_id":null,"corpus_id":3955365,"text":"Cysteine-to-valine substitution at peptide position 9 tightens binding to HLA-A2, improves soluble TCR binding, and repositions the peptide main chain.","confidence":0.98,"paper":{"corpus_id":3955365,"title":"Structural and kinetic basis for heightened immunogenicity of T cell vaccines","url":"https://sah.borca.ai/papers/3955365"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.98,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_2eb134f19ebedf94bcd6652f912c44af","name":"soluble TCR binding","description":"Binding of a purified, soluble T cell receptor to a peptide-MHC complex.","types":["binding measurement"],"url":"https://sah.borca.ai/concepts/co_2eb134f19ebedf94bcd6652f912c44af"},{"public_id":"co_3d918823fc618e99d4d390fba3dcca77","name":"HLA-A2","description":"A human major histocompatibility class I molecule that presents peptide antigens.","types":["MHC class I molecule"],"url":"https://sah.borca.ai/concepts/co_3d918823fc618e99d4d390fba3dcca77"},{"public_id":"co_b7902011e055338e79923f7b93db7762","name":"cysteine-to-valine substitution","description":"An amino acid substitution at peptide position 9 that changes cysteine to valine.","types":["mutation"],"url":"https://sah.borca.ai/concepts/co_b7902011e055338e79923f7b93db7762"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_015dc08829e7012ef0df91b1abbe9f9b"}